Gilead Sciences (GILD) PT Lowered to $122 at RBC Capital

May 8, 2026 7:30 AM

RBC Capital analyst Brian Abrahams lowered the price target on Gilead Sciences (NASDAQ: GILD) to $122.00 (from $123.00) while maintaining a Sector Perform rating.

No results found